Family history of hematopoietic malignancy and risk of lymphoma

被引:97
作者
Chang, ET
Smedby, KE
Hjalgrim, H
Porwit-MacDonald, A
Roos, G
Glimelius, B
Adami, HO
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden
[2] Karolinska Inst, Dept Pathol & Oncol, SE-17177 Stockholm, Sweden
[3] State Serum Inst, Dept Epidemiol Res, Danish Epidemiol Sci Ctr, Copenhagen, Denmark
[4] Umea Univ, Dept Med Biosci, Umea, Sweden
[5] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2005年 / 97卷 / 19期
关键词
D O I
10.1093/jnci/dji293
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. A family history of hematopoietic malignancy is associated with an increased risk of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL), although the magnitude of the relative risk is unclear. We estimated the association between familial hematopoietic cancer and risk of lymphoma using validated, registry-based family data, and we also investigated whether associations between some environmental exposures and risk of lymphoma vary between individuals with and without such a family history. Methods: In a population-based case-control study of malignant lymphoma, 1506 case patients and 1229 control subjects were linked to the Swedish Multi-Generation Register and then to the Swedish Cancer Register to ascertain history of cancer in first-degree relatives of patients with malignant lymphoma. Multiple logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations with the risk of lymphoma. Results: A history of hematopoietic malignancy in any first-degree relative was associated with an increased risk of all NHL (OR = 1.8, 95% CI = 1.2 to 2.5), common B-cell NHL subtypes, and HL. Relative risks were generally stronger in association with sibling hematopoietic cancer (OR for all NHL = 3.2, 95% CI = 1.3 to 7.6) than with parental hematopoietic cancer (OR = 1.6, 95% CI = 1.1 to 2.3). A family history of NHL or chronic lymphocytic leukemia (CLL) was associated with an increased risk of several NHL subtypes and HL, whereas familial multiple myeloma was associated with a higher risk of follicular lymphoma. There was no statistically significant heterogeneity in NHL risk associations with environmental factors between individuals with and without familial hematopoietic malignancy. Conclusions: The increased risk of NHL and HL among individuals with a family history of hematopoietic malignancy was approximately twofold for both lymphoma types. There was no evidence that etiologic associations varied between familial NHL and nonfamilial NHL.
引用
收藏
页码:1466 / 1474
页数:9
相关论文
共 45 条
[1]   EVIDENCE OF AN ASSOCIATION BETWEEN NON-HODGKINS-LYMPHOMA AND SKIN-CANCER [J].
ADAMI, J ;
FRISCH, M ;
YUEN, J ;
GLIMELIUS, B ;
MELBYE, M .
BRITISH MEDICAL JOURNAL, 1995, 310 (6993) :1491-1495
[2]   EPIDEMIOLOGIC EVIDENCE FOR THE 2-DISEASE HYPOTHESIS IN HODGKINS-DISEASE [J].
ALEXANDER, FE ;
MCKINNEY, PA ;
WILLIAMS, J ;
RICKETTS, TJ ;
CARTWRIGHT, RA .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1991, 20 (02) :354-361
[3]   Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database [J].
Altieri, A ;
Bermejo, JL ;
Hemminki, K .
BLOOD, 2005, 106 (02) :668-672
[4]  
[Anonymous], 1995, WHO TECHN REP SER, V854, P1, DOI DOI 10.1002/(sici)1520-6300(1996)8:63.0.co
[5]  
2-i
[6]  
BANKS PM, 1992, CANCER RES, V52, pS5453
[7]   Dietary factors and risk of non-Hodgkin lymphoma in men and women [J].
Chang, ET ;
Smedby, KE ;
Zhang, SM ;
Hjalgrim, H ;
Melbye, M ;
Öst, Å ;
Glimelius, B ;
Wolk, A ;
Adami, HO .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (02) :512-520
[8]   Alcohol intake and risk of non-Hodgkin lymphoma in men and women [J].
Chang, ET ;
Smedby, KE ;
Zhang, SM ;
Hjalgrim, H ;
Melbye, M ;
Öst, A ;
Wolk, A ;
Adami, HO ;
Glimelius, B .
CANCER CAUSES & CONTROL, 2004, 15 (10) :1067-1076
[9]  
Chatterjee N, 2004, CANCER EPIDEM BIOMAR, V13, P1415
[10]  
Chiu BCH, 2004, CANCER EPIDEM BIOMAR, V13, P525